First Trust Advisors LP Magenta Therapeutics, Inc. Transaction History

First Trust Advisors LP

  • $101 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$0.97 - $3.08 $1,453 - $4,613
-1,498 Reduced 2.64%
55,275 $66,000
Q1 2022

May 13, 2022
SELL
$2.55 - $5.23 $8,402 - $17,232
-3,295 Reduced 5.49%
56,773 $165,000
Q4 2021

Feb 08, 2022
BUY
$4.43 - $8.33 $33,712 - $63,391
7,610 Added 14.51%
60,068 $266,000
Q3 2021

Nov 15, 2021
BUY
$6.07 - $9.89 $318,420 - $518,809
52,458 New
52,458 $382,000

Others Institutions Holding MGTA

# of Institutions
2
Shares Held
442K
Call Options Held
0
Put Options Held
0
View Full List

About Magenta Therapeutics, Inc.

MGTA Quotes by TradingView
  • Ticker MGTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 58,890,500
  • Description
  • Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...
More about MGTA
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email